Richard B. Hancock

2020

In 2020, Richard B. Hancock earned a total compensation of $773.7K as Former Interim President and Chief Executive Officer at Peregrine Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$74,266
Option Awards$133,728
Salary$454,216
Stock Awards$90,374
Other$21,153
Total$773,737

Hancock received $454.2K in salary, accounting for 59% of the total pay in 2020.

Hancock also received $74.3K in non-equity incentive plan, $133.7K in option awards, $90.4K in stock awards and $21.2K in other compensation.

Rankings

In 2020, Richard B. Hancock's compensation ranked 9,623rd out of 13,090 executives tracked by ExecPay. In other words, Hancock earned more than 26.5% of executives.

ClassificationRankingPercentile
All
9,623
out of 13,090
27th
Division
Manufacturing
4,134
out of 5,620
26th
Major group
Chemicals And Allied Products
1,690
out of 2,253
25th
Industry group
Drugs
1,482
out of 1,953
24th
Industry
Pharmaceutical Preparations
1,092
out of 1,458
25th

Pay ratio

Richard B. Hancock's Pay$773,737
Median Employee's Pay$83,115
Pay Ratio

9

to 1

In 2020, the annual total compensation of Richard B. Hancock was $773,737.

The annual total compensation of the median employee at Peregrine Pharmaceuticals was $83,115.

The ratio of Richard B. Hancock's pay to the pay of median employee was therefore 9 to one.

Source: SEC filing on August 27, 2020.

Hancock's colleagues

We found three more compensation records of executives who worked with Richard B. Hancock at Peregrine Pharmaceuticals in 2020.

2020

Mark Ziebell

Peregrine Pharmaceuticals

General Counsel

2020

Daniel Hart

Peregrine Pharmaceuticals

Chief Financial Officer

2020

Roger Lias

Peregrine Pharmaceuticals

Chief Executive Officer

News

You may also like